President-elect Donald Trump’s incoming administration could try to remove fluoride from drinking water, according to Robert F. Kennedy Jr. Kennedy, who was tapped last week by Trump to lead the Department of Health and Human Services, called fluoride an “industrial waste” and linked it to cancer and other diseases and disorders while campaigning for Trump….
The right AI model applied to the right problem exponentially enhances our ability to match patients with potentially life saving treatments faster and more effectively. The only “trick” required for truly successful AI integration — in life sciences or any other facet of the healthcare industry — is clarity of purpose. The post First Principles…
Riverside Health is reporting an increase in revenue and net margins as a result of adopting Abridge’s ambient AI technology. The tool listens to doctor-patient interactions and generates clinical notes — which not only alleviates physicians’ burnout, but also improves their documentation accuracy. The Virginia-based health system saw a 14% increase in HCC diagnoses documented…
This brief identifies time-bound PEPFAR authorities and also provides a detailed side-by-side comparison of PEPFAR’s authorizing legislation over time.
For nursing to shape its future in an AI-driven world, its leaders and practitioners must be present, informed, and engaged in every step of its development and deployment. The post The Critical Need For Nurses To Play An Active Role In AI Implementation appeared first on MedCity News.
Valentino Valdez was given his birth certificate, his Social Security card, a T-shirt, and khaki pants when he was released from a Texas prison in 2019 at age 21. But he didn’t have health insurance, mental health medications, or access to a doctor, he said. Three years later, he landed in an inpatient hospital after…
The vast majority of older adults want to age at home. To support that goal, doctors should encourage them to consider their care options — long before they need assistance. The post Through Early Discussions About Elder Care, Doctors Can Empower Seniors to Age in Place appeared first on MedCity News.
Novartis’s Fabhalta is the first FDA-approved therapy for C3 glomerulopathy. But Apellis Pharmaceuticals’ Empaveli has superior clinical data, and that drug has been submitted for FDA review in the same rare kidney disease as well as another one that does not yet have an approved therapy. The post Novartis Nabs First FDA Nod in Rare…
WellTheory has launched a new program that will address the link between autoimmune disease and hormone imbalances. The post WellTheory Announces Women’s Health Program to Address Hormonal Conditions appeared first on MedCity News.
Though chronic disease treatment is rapidly expanding, balancing the latest medication with proven initiatives can help employers manage rising healthcare costs wherever you fall on the GLP-1 coverage spectrum. The post Considering Covering GLP-1s? Here’s What You Need to Know appeared first on MedCity News.